| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7a762fb574c7723ed2e9f084eac88115 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 |
| filingDate |
1985-08-15^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1986-08-12^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f7ee571f5f3a7c6be47a74f03abe3a2 |
| publicationDate |
1986-08-12^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4605648-A |
| titleOfInvention |
Treatment of Herpes Simplex viruses |
| abstract |
A method of suppressing the outbreaks of Herpes Simplex virus lesions and related symptoms in humans by administering to an individual who has experienced Herpes Simplex virus outbreaks a therapeutically effective dosage of an androgenic flurosteroid. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004106556-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007031923-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1433481-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7439052-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011039952-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003133929-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8506968-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013034500-A1 |
| priorityDate |
1985-08-15^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |